Antileishmanial activities of several classes of aromatic dications

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 3, 2002, Pages 797-807

  Brendle, James J ^a   Outlaw, Abram ^a   Kumar, Arvind ^a   Boykin, David W ^a   Patrick, Donald A ^a   Tidwell, Richard R ^a   Werbovetz, Karl A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 BIS(4 AMIDINOPHENYL)THIOPHENE; AMIDINE; ANTILEISHMANIAL AGENT; ANTIPARASITIC AGENT; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; CARBAZOLE DERIVATIVE; DIBENZOFURAN DERIVATIVE; DIBENZOTHIOPHENE DERIVATIVE; FURAN DERIVATIVE; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CRYPTOSPORIDIUM PARVUM; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; IC 50; LEISHMANIA DONOVANI; MACROPHAGE; NONHUMAN; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; BENZIMIDAZOLES; CARBAZOLES; CATIONS; CELL DIVISION; FURANS; HUMANS; INDICATORS AND REAGENTS; LEISHMANIA DONOVANI; LEISHMANIA MEXICANA; MACROPHAGES; MICE; PENTAMIDINE; STRUCTURE-ACTIVITY RELATIONSHIP; THIOPHENES;

EID: 0036171856     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.3.797-807.2002     Document Type: Article

References (35)

1. Pentamidine uptake in Leishmania donovani and Leishmania amazonensis promastigotes and axenic amastigotes
2. Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity
3. Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis
4. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
5. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model
6. Dicationic furans inhibit development of Cryptosporidium parvum in HSD/ICD suckling Swiss mice
7. Antipneumocystis activity of bis-amidoximes and bis-O-alkylamidoxime prodrugs
8. 2.5-Bis[4-(N-alkylamidino)phenyl]furans as anti-Pneumocystis carinii agents
9. An axenic amastigote system for drug screening
10. Effects of cationic diamidines on polyamine content and uptake on Leishmania infantum in in vitro cultures
11. Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)furans
12. Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)thiophenes and pyrroles
13. Structure-in vitro activity relationships of pentamidine analogs and dication-substituted bis-benzimidazoles as new antifungal agents
14. 2,4-Diphenylfuran diamidines as novel anti-Pneumocystis carinii pneumonia agents
15. Pentamidine isethionate: A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia
16. Treatment of Old World cutaneous leishmaniasis by pentamidine isethionate: An open study of 11 patients
17. Extended aromatic furan amidino derivatives as anti-Pneumocystis carinii agents
18. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis
19. Palladium catalyzed cross-coupling reactions for the synthesis of 2,5-disubstituted furans
20. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani
21. Electrophilic aromatic substitution. Part XV. The kinetics, mechanism, and products of nitrodebromination in sulfuric acid
22. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazine and suramin
23. An in vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani
24. Practical progress and new drugs for changing patterns of leishmaniasis
25. Anti-Pneumocystis carinii pneumonia activity of dicationic carbazoles
26. Synthesis and anti-Pneumocystis carinii pneumonia activity of novel dicationic dibenzothiophenes and diamidoxime prodrugs
27. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: Course and impact from 1984 to 1994
28. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents
29. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs
30. Successful treatment of Columbian cutaneous leishmaniasis with four injections of pentamidine
31. Short-course of oral miltefosine for treatment of visceral leishmaniasis
32. Evaluation of the influence of compound structure on stackeddimer formation in the DNA minor groove
33. Dicationic dibenzofuran derivatives as anti-Pneumocystis carinii pneumonia agents: Synthesis, DNA binding affinity, and anti-P. carinii activity in an immunosuppressed rat model
34. Purification, characterization, and drug susceptibility of tubulin from Leishmania
35. Novel alkylpolyamine analogues that possess both antitrypanosomal and antimicrosporidial activity